Wrapmanager Inc Argenx Se Transaction History

Wrapmanager Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$369.35 - $548.43 $160,667 - $238,567	435 New	435 $213,000
Q2 2021 Aug 04, 2021	SELL	$257.11 - $319.92 $508,049 - $632,161	-1,976 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$268.3 - $380.31 $123,686 - $175,322	461 Added 30.43%	1,976 $544,000
Q4 2020 Feb 08, 2021	BUY	$248.13 - $308.36 $39,204 - $48,720	158 Added 11.64%	1,515 $446,000
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $3,448 - $4,360	-16 Reduced 1.17%	1,357 $356,000
Q2 2020 Aug 11, 2020	BUY	$127.44 - $232.72 $174,975 - $319,524	1,373 New	1,373 $309,000
Q1 2020 May 08, 2020	SELL	$108.83 - $165.23 $150,947 - $229,174	-1,387 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$106.59 - $164.21 $147,840 - $227,759	1,387 New	1,387 $223,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

Stay updated on Wrapmanager Inc with notifications on news.